Microbiome and cancer immunotherapies.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 38631286.
- Also identified by DOI 10.1016/j.xcrm.2024.101514 and PMC identifier 11031416.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Here, we present 3 different perspectives on how the microbiome has impacted cancer patients, treatment, and clinical studies. We hear about the challenges of implementing microbiome analyses into the clinics, the impact these analyses might have on patients' care, and treatment in the future, specifically for gastric cancer treatment. These are a few of the many voices that are highlighting the role of the microbiome in cancer development, treatment, and clinical outcomes.
Medical subject headings
- Microbiota
- Stomach Neoplasms